tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Ascendis Pharma A/S

ASND
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
243.910USD
-7.160-2.85%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
15.12B์‹œ๊ฐ€์ด์•ก
35.15P/E TTM

ASND ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Ascendis Pharma A/S์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Ascendis Pharma A/S ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 7, 2026
EPS / ์˜ˆ์ƒ
8.83/0.17
์ˆ˜์ต / ์˜ˆ์ƒ
210.32M/229.26M
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
854.80M
126.42%
EPS(YoY)
-4.42
34.64%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
STRONG BUY
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
์žฌ๋ฌด ์ง€ํ‘œ
EPS
791.12%11.79
3.28%-0.64
38.64%-1.18
64.93%-0.72
31.41%-1.71
60.71%-0.67
37.00%-1.92
-3.21%-2.04
-36.29%-2.49
51.08%-1.70
---3.05
---1.98
---1.82
---3.46
---6.70
----
----
----
----
----
----
----
์ˆ˜์ต
153.66%289.14M
--208.51M
235.56%184.29M
315.63%135.49M
-0.00%89.41M
----
22.33%54.92M
-26.27%32.60M
193.53%89.41M
----
188.26%44.90M
639.01%44.21M
368.91%30.46M
387.41%21.46M
1506.20%15.58M
588.96%5.98M
961.66%6.50M
881.50%4.40M
-58.58%969.68K
-28.52%868.31K
-69.97%611.88K
-80.38%448.64K
์ˆœ์ด์ต
790.64%737.90M
---28.27M
44.15%-52.61M
66.37%-33.31M
31.41%-83.81M
----
37.87%-94.21M
12.56%-99.05M
-21.47%-122.18M
----
11.90%-151.62M
-43.44%-113.28M
15.76%-100.58M
-103.87%-194.43M
-145.86%-172.10M
30.83%-78.97M
-131.83%-119.40M
18.16%-95.37M
32.28%-70.00M
-42.16%-114.17M
11.17%-51.50M
-58.96%-116.53M
์ˆœ์ด์ต๋ฅ 
372.27%255.21%
38.69%-13.56%
83.36%-28.55%
91.91%-24.58%
31.41%-93.73%
64.94%-22.12%
49.21%-171.52%
-18.59%-303.85%
58.62%-136.65%
93.04%-63.09%
---337.73%
---256.23%
---330.21%
---905.91%
---1328.86%
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
12.40%92.90%
-1.60%90.47%
11.04%89.54%
17.54%80.10%
-10.27%82.65%
7.06%91.94%
-4.71%80.63%
-6.28%68.15%
6.80%92.11%
10.55%85.87%
--84.62%
--72.72%
--86.24%
--77.67%
--75.16%
----
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-43.93%44.76%
-7.85%66.93%
-13.59%70.46%
-17.87%72.85%
-4.25%79.82%
-6.93%72.63%
6.94%81.55%
44.44%88.70%
59.39%83.37%
67.28%78.04%
--76.25%
--61.41%
--52.30%
--46.65%
--43.45%
----
----
----
----
----
----
----
์ˆ˜์ต
153.66%289.14M
--208.51M
235.56%184.29M
315.63%135.49M
-0.00%89.41M
----
22.33%54.92M
-26.27%32.60M
193.53%89.41M
----
188.26%44.90M
639.01%44.21M
368.91%30.46M
387.41%21.46M
1506.20%15.58M
588.96%5.98M
961.66%6.50M
881.50%4.40M
-58.58%969.68K
-28.52%868.31K
-69.97%611.88K
-80.38%448.64K
์˜์—… ์ด์ต
126.64%29.09M
--8.34M
110.33%9.49M
62.38%-45.39M
-86.91%-85.65M
----
26.87%-91.87M
8.15%-120.67M
64.83%-45.82M
----
14.66%-125.63M
4.66%-131.38M
-6.98%-130.30M
-36.47%-138.16M
-74.30%-147.20M
-37.88%-137.80M
-19.14%-121.80M
-26.22%-101.23M
-26.17%-84.45M
-42.43%-99.94M
-52.52%-102.24M
-35.58%-80.20M
์ˆœ์ด์ต
790.64%737.90M
---28.27M
44.15%-52.61M
66.37%-33.31M
31.41%-83.81M
----
37.87%-94.21M
12.56%-99.05M
-21.47%-122.18M
----
11.90%-151.62M
-43.44%-113.28M
15.76%-100.58M
-103.87%-194.43M
-145.86%-172.10M
30.83%-78.97M
-131.83%-119.40M
18.16%-95.37M
32.28%-70.00M
-42.16%-114.17M
11.17%-51.50M
-58.96%-116.53M
์œ ๋™์ž์‚ฐ
26.48%1.32B
--934.28M
-5.05%878.00M
43.81%816.94M
31.80%816.13M
----
34.99%924.73M
-10.14%568.07M
-15.69%619.22M
----
-37.73%685.04M
-41.47%632.16M
-31.14%734.42M
19.46%865.65M
31.99%1.10B
117.57%1.08B
89.21%1.07B
16.76%724.65M
2.93%833.41M
19.36%496.39M
11.61%563.71M
11.32%620.66M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
32.14%1.32B
--900.92M
6.88%851.00M
4.41%801.54M
5.28%784.26M
----
300.41%796.26M
328.00%767.67M
314.13%744.96M
----
36.67%198.86M
60.42%179.36M
98.29%179.89M
644.56%671.89M
43.82%145.50M
87.19%111.81M
51.67%90.72M
103.79%90.24M
84.93%101.17M
29.86%59.73M
56.22%59.81M
1.15%44.28M
์ด ์ž์‚ฐ
95.99%2.35B
--1.10B
-4.10%996.16M
35.82%932.62M
25.64%940.07M
----
27.27%1.04B
-10.65%686.68M
-14.61%748.26M
----
-37.08%816.16M
-40.36%768.49M
-33.12%876.28M
4.71%1.02B
23.53%1.30B
78.04%1.29B
65.49%1.31B
18.73%975.56M
18.21%1.05B
52.61%723.75M
39.15%791.76M
33.09%821.63M
๋ถ€์ฑ„ ์ด๊ณ„
25.76%1.78B
--1.23B
1.34%1.15B
11.86%1.09B
14.21%1.11B
----
27.84%1.13B
38.06%977.48M
33.90%970.33M
----
5.69%884.80M
1.40%708.01M
8.13%724.65M
327.99%774.64M
353.97%837.19M
400.02%698.25M
402.84%670.19M
52.99%181.00M
129.73%184.41M
97.78%139.64M
100.56%133.28M
62.89%118.31M
์ž๋ณธ ์ด๊ณ„
366.97%572.15M
---137.17M
-62.48%-150.17M
44.71%-160.80M
24.30%-168.10M
----
-34.66%-92.42M
-580.78%-290.80M
-246.46%-222.08M
----
-114.92%-68.64M
-89.75%60.49M
-76.31%151.63M
-68.93%246.86M
-46.86%459.97M
1.06%590.31M
-2.79%640.11M
12.97%794.56M
7.13%865.62M
44.71%584.10M
31.03%658.48M
29.12%703.32M
์ˆœ์˜์—…์ด์ต
43.98%-9.05M
--61.83M
103.48%1.86M
88.66%-6.29M
86.62%-12.68M
----
54.27%-53.31M
61.13%-55.52M
28.97%-94.72M
----
-15.79%-116.57M
-18.24%-142.84M
-7.17%-133.35M
-19.78%-132.81M
-18.50%-100.68M
-23.43%-120.81M
-85.87%-124.43M
-46.38%-110.88M
-73.06%-84.96M
-104.38%-97.88M
-9.47%-66.94M
-68.65%-75.75M
์ˆœํˆฌ์ž
-897.52%-7.92M
---2.86M
90.43%-45.72K
-775.44%-3.72M
-109.33%-622.62K
----
-102.30%-477.68K
-98.74%550.58K
-96.51%6.67M
----
44.61%20.77M
356.15%43.80M
420.96%191.03M
99.26%-747.09K
-19.30%14.36M
2.42%9.60M
248.44%36.67M
-68.72%-100.64M
-14.16%17.80M
104.65%9.38M
-339.30%-24.70M
-5691.65%-59.65M
์ˆœ์žฌ๋ฌดํ™œ๋™
-112.21%-43.19M
--7.18M
-91.75%33.52M
369.20%5.98M
-192.93%-15.96M
----
203.26%406.34M
-3.21%-2.22M
2798.26%17.18M
----
173178.83%133.99M
0.77%-2.15M
-100.17%-636.62K
106.82%1.26M
-100.02%-77.42K
-283.66%-2.17M
2306619.21%378.40M
-314.47%-18.55M
-34.96%322.88M
-84.10%1.18M
101.60%16.40K
122.40%8.65M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Ascendis Pharma A/S์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 854.80M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 377.53M์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 1.32B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.52์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ด์ž์‚ฐ์€ 1.55B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 26.26์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ด๋ถ€์ฑ„๋Š” 1.74B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 30.36์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ด์ž๋ณธ์€ -193.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -76.11์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ˆœ์˜์—…์†Œ๋“์€ -161.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 44.11์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ˆœํˆฌ์ž๋Š” -10.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -241.09์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Ascendis Pharma A/S์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 43.12M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -90.64์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -4.42์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 34.64์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -270.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.04์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -31.67์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 69.54์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 86.82์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -1.15์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 66.93์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -7.85์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -18.37์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 51.28์ž…๋‹ˆ๋‹ค.

Ascendis Pharma A/S์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Ascendis Pharma A/S์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -161.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 44.11์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ